rs17887200

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000359597.8(TP53):​c.994-1509A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0702 in 152,152 control chromosomes in the GnomAD database, including 732 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.070 ( 732 hom., cov: 32)

Consequence

TP53
ENST00000359597.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.43

Publications

7 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP53ENST00000359597.8 linkc.994-1509A>G intron_variant Intron 8 of 8 1 ENSP00000352610.4
TP53ENST00000413465.6 linkc.783-5739A>G intron_variant Intron 6 of 6 1 ENSP00000410739.2
TP53ENST00000714356.1 linkc.984-1509A>G intron_variant Intron 9 of 9 ENSP00000519623.1
TP53ENST00000635293.1 linkn.984-328A>G intron_variant Intron 10 of 11 5 ENSP00000488924.1

Frequencies

GnomAD3 genomes
AF:
0.0701
AC:
10651
AN:
152034
Hom.:
730
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0909
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0518
Gnomad ASJ
AF:
0.0159
Gnomad EAS
AF:
0.356
Gnomad SAS
AF:
0.163
Gnomad FIN
AF:
0.0174
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.0451
Gnomad OTH
AF:
0.0664
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0702
AC:
10681
AN:
152152
Hom.:
732
Cov.:
32
AF XY:
0.0712
AC XY:
5299
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0917
AC:
3809
AN:
41520
American (AMR)
AF:
0.0518
AC:
791
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0159
AC:
55
AN:
3468
East Asian (EAS)
AF:
0.356
AC:
1830
AN:
5136
South Asian (SAS)
AF:
0.160
AC:
772
AN:
4826
European-Finnish (FIN)
AF:
0.0174
AC:
184
AN:
10604
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.0451
AC:
3067
AN:
67996
Other (OTH)
AF:
0.0686
AC:
145
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
485
970
1456
1941
2426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0524
Hom.:
74
Bravo
AF:
0.0748
Asia WGS
AF:
0.240
AC:
832
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.045
DANN
Benign
0.68
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17887200; hg19: chr17-7571071; COSMIC: COSV53538686; COSMIC: COSV53538686; API